← Leaderboards
Utpal Pal
Univ Of Maryland, College Park
$14,444,347
Attributed
$16,825,343
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,495,436 · 15
By mechanism
P01$13,102,324 · 5
R01$11,145,037 · 4
R21$823,625 · 2
R41$600,000 · 1
R03$467,250 · 2
R56$357,200 · 1
Top collaborators
- Erol Fikrig6 shared
- Joao Pedra6 shared
- Matthias Johannes Schnell5 shared
- Albert Icksang Ko2 shared
- Michel Ledizet2 shared
- Siba K Samal2 shared
Most similar at Univ Of Maryland, College Park
Same institution · by research overlap
- Matthias Johannes Schnell$34,760,060
- Xiuli Yang$595,300
- Siba K Samal$1,024,194
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenBorrelia BurgdorferiTicksLyme DiseaseInfectionVectorMicrobialProteinsOrder SpirochaetalesUnited StatesImmunityTransmission ProcessPathogenesisBorreliaBiologyEnzooticBlack-Legged TickAntigensBaseMolecularResponseComplexTick-Borne InfectionsCells
Grant awards (55)
Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens$1,941,828
P01 · FY2025 · AI · contact PI
Multivalent Tick-Microbe targeted Lyme disease vaccines$698,515
R01 · FY2025 · AI · contact PI
A cross-species signaling system in tick immunity and development$518,099
R01 · FY2025 · AI · contact PI
Signaling Pathways Regulating Vector Immune-Developmental Cascades$490,419
P01 · FY2025 · AI · contact PI
Administrative Core$241,922
P01 · FY2025 · AI · contact PI
Multivalent Tick-Microbe targeted Lyme disease vaccines$707,645
R01 · FY2024 · AI · contact PI
Borrelia gene products critical for natural infection cycle$474,580
R01 · FY2024 · AI · contact PI
Borrelia gene products critical for natural infection cycle$486,653
R01 · FY2023 · AI · contact PI
Tick Immune Signaling, Microbiota, and Acquisition of Borrelia burgdorferi and Anaplasma phagocytophilum$1,537,478
P01 · FY2022 · AI · contact PI
Multivalent Tick-Microbe targeted Lyme disease vaccines$716,967
R01 · FY2022 · AI · contact PI
Borrelia gene products critical for natural infection cycle$498,666
R01 · FY2022 · AI · contact PI
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens$386,250
P01 · FY2022 · AI · contact PI
Administrative Supplement: Borrelia gene products critical for natural infection cycle$223,177
R01 · FY2022 · AI · contact PI
Administrative Core$153,728
P01 · FY2022 · AI · contact PI
Tick Immune Signaling, Microbiota, and Acquisition of Borrelia burgdorferi and Anaplasma phagocytophilum$1,537,478
P01 · FY2021 · AI · contact PI
Multivalent Tick-Microbe targeted Lyme disease vaccines$712,910
R01 · FY2021 · AI · contact PI
Borrelia gene products critical for natural infection cycle$498,543
R01 · FY2021 · AI · contact PI
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens$386,250
P01 · FY2021 · AI · contact PI
Administrative Core$153,728
P01 · FY2021 · AI · contact PI
Tick Immune Signaling, Microbiota, and Acquisition of Borrelia burgdorferi and Anaplasma phagocytophilum$1,537,478
P01 · FY2020 · AI · contact PI
Multivalent Tick-Microbe targeted Lyme disease vaccines$707,956
R01 · FY2020 · AI · contact PI
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens$386,250
P01 · FY2020 · AI · contact PI
Administrative Core$153,728
P01 · FY2020 · AI · contact PI
Tick Immune Signaling, Microbiota, and Acquisition of Borrelia burgdorferi and Anaplasma phagocytophilum$1,537,478
P01 · FY2019 · AI · contact PI
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens$386,250
P01 · FY2019 · AI · contact PI
BBA57-Mediated Borrelial Persistence, Genesis of Inflammation and Immunity$380,000
R01 · FY2019 · AI · contact PI
Administrative Core$153,728
P01 · FY2019 · AI · contact PI
Tick Immune Signaling, Microbiota, and Acquisition of Borrelia burgdorferi and Anaplasma phagocytophilum$1,578,353
P01 · FY2018 · AI · contact PI
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens$386,250
P01 · FY2018 · AI · contact PI
BBA57-Mediated Borrelial Persistence, Genesis of Inflammation and Immunity$380,000
R01 · FY2018 · AI · contact PI
Administrative Core$153,728
P01 · FY2018 · AI · contact PI
BORRELIA GENE PRODUCTS CRITICAL FOR NATURAL INFECTION CYCLE$380,000
R01 · FY2017 · AI · contact PI
BBA57-Mediated Borrelial Persistence, Genesis of Inflammation and Immunity$380,000
R01 · FY2017 · AI · contact PI
BBA57-Mediated Borrelial Persistence, Genesis of Inflammation and Immunity$380,000
R01 · FY2016 · AI · contact PI
BORRELIA GENE PRODUCTS CRITICAL FOR NATURAL INFECTION CYCLE$380,000
R01 · FY2016 · AI · contact PI
BBA57-Mediated Borrelial Persistence, Genesis of Inflammation and Immunity$380,000
R01 · FY2015 · AI · contact PI
BORRELIA GENE PRODUCTS CRITICAL FOR NATURAL INFECTION CYCLE$380,000
R01 · FY2015 · AI · contact PI
RNA Detection as an Improved Diagnostic Assay for Human Leptospirosis$300,000
R41 · FY2015 · AI
BORRELIA GENE PRODUCTS CRITICAL FOR NATURAL INFECTION CYCLE$380,000
R01 · FY2014 · AI · contact PI
RNA Detection as an Improved Diagnostic Assay for Human Leptospirosis$300,000
R41 · FY2014 · AI
NDV-vectored Lyme disease vaccines$228,000
R21 · FY2014 · AI · contact PI
Borella Gene Products Critical For Natural Infection Cycle$357,200
R56 · FY2013 · AI · contact PI
NDV-vectored Lyme disease vaccines$190,000
R21 · FY2013 · AI · contact PI
Borrelia gene products critical for natural infection cycle$367,538
R01 · FY2012 · AI · contact PI
Borrelia gene products critical for natural infection cycle$367,538
R01 · FY2011 · AI · contact PI
Borrelia gene products critical for natural infection cycle$371,250
R01 · FY2010 · AI · contact PI
Borrelia gene products critical for natural infection cycle$375,000
R01 · FY2009 · AI · contact PI
Function of selected vector-induced B. burgdorferi gene-products$221,250
R21 · FY2009 · AI · contact PI
Molecular trigger of Lyme arthritis$73,500
R03 · FY2009 · AR · contact PI
Function of selected vector-induced B. burgdorferi gene-products$184,375
R21 · FY2008 · AI · contact PI
Molecular trigger of Lyme arthritis$73,500
R03 · FY2008 · AR · contact PI
Molecular trigger of Lyme arthritis$75,000
R03 · FY2007 · AR · contact PI
OspA-mediated Borrelia adherence to tick gut$81,750
R03 · FY2004 · AR
OspA-mediated Borrelia adherence to tick gut$81,750
R03 · FY2003 · AR
OspA-mediated Borrelia adherence to tick gut$81,750
R03 · FY2002 · AR